As was noted in this space some time ago, the Pennsylvania Supreme Court was considering an employer’s petition for allowance ...

By contrast, ChatGPT 4.0 hit 100% accuracy for diagnostic testing and a 33% accuracy rate for surgical intervention ...

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

A chart-review study found low-dose dexamethasone mixed with local anesthetic was the optimal injectate for use in ILESIs for lumbar radiculopathy.

Vertex Pharmaceuticals beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.Please watch the video at Investors.com - How To Buy ...

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $476 from $473 and keeps an Equal ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report). The ...

Coming off of a strong third quarter, Vertex Pharmaceuticals is nearing several important milestones, including the potential approvals of vanzacaftor triple in cystic fibrosis and the non-opioid ...

Dr. Romano's specialties are spine, herniated/ruptured disc, neck and back pain, lumbar radiculopathy/sciatica, cervical radiculopathy, spinal stenosis and myelopathy, degenerative disc disease, ...